This is the first report to delineate a pathophysiological role of the anomalous MAO-A activity upregulated by chronic intermittent hypoxia in oxidative stress and inflammation, which significantly activates the IDO-1 activity and contributes to serotonin deficiency and neurodegeneration closely associated with the clinical manifestation of the brain of patients with depression. Here, MAOA is linked to depressive disorder.